TSXV - Delayed Quote CAD

PharmaCielo Ltd. (PCLO.V)

Compare
0.0900
0.0000
(0.00%)
At close: January 9 at 2:25:07 PM EST
Loading Chart for PCLO.V
DELL
  • Previous Close 0.0900
  • Open 0.0950
  • Bid 0.0900 x --
  • Ask 0.0950 x --
  • Day's Range 0.0850 - 0.0950
  • 52 Week Range 0.0650 - 0.2900
  • Volume 28,000
  • Avg. Volume 199,363
  • Market Cap (intraday) 15.277M
  • Beta (5Y Monthly) 2.39
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date Dec 2, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with Benuvia Operations, LLC to produce cGMP pharmaceutical-grade CBD active pharmaceutical ingredients. PharmaCielo Ltd. is headquartered in Toronto, Canada.

www.pharmacielo.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PCLO.V

View More

Performance Overview: PCLO.V

Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

PCLO.V
20.00%
S&P/TSX Composite index
1.84%

1-Year Return

PCLO.V
64.00%
S&P/TSX Composite index
18.97%

3-Year Return

PCLO.V
90.82%
S&P/TSX Composite index
18.92%

5-Year Return

PCLO.V
97.31%
S&P/TSX Composite index
46.05%

Compare To: PCLO.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PCLO.V

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    15.28M

  • Enterprise Value

    36.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.82

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    13.92

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -19.83%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.62M

  • Net Income Avi to Common (ttm)

    -14.15M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.69k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.59M

Research Analysis: PCLO.V

View More

People Also Watch